TMCI:NASDAQ
Treace Medical Concepts, Inc
US$ 5,27
arrow_downward
-1,31%(-0,070) 1D
13 nov, 16:00:00 GMT-5 · USD
search
Alle symbolen
| Symbool | Prijs | Wijziging | Wijzigingspercentage |
|---|
insights_autoBelangrijkste inzichten voor TMCI genereren…
Openen
US$ 5,32
Hoog
US$ 5,32
Laag
US$ 4,95
Beursw.
345,50 mln.
Gem. vol.
294,14K
Volume
0,00
52 wk hoog
US$ 5,44
52 wk laag
US$ 1,17
WPA
US$ -0,86
Bèta
1,59
Uitstaande aandelen
65,56 mln.
Aantal medewerkers
450
Openen
US$ 5,32
Hoog
US$ 5,32
Laag
US$ 4,95
Beursw.
345,50 mln.
Gem. vol.
294,14K
Volume
0,00
52 wk hoog
US$ 5,44
52 wk laag
US$ 1,17
WPA
US$ -0,86
Bèta
1,59
Uitstaande aandelen
65,56 mln.
Aantal medewerkers
450
Nieuwsartikelen
Van webbronnen en nieuwspartners
TradingKey
·
1 dag geleden
S&P 500 Forecast: Index Poised to Retest Record High in November After 500-Point Pullback, Biggest Daily Gain in Nearly Seven Months
The Motley Fool
·
11 uur geleden
This Dividend King Yields 5 Times the S&P 500. Is It a Buy Now?
BigGo Finance
·
17 uur geleden
Goldman Sachs Sets 8,700 S&P 500 Target for 2027, Sees 14% Upside as AI Capex Peaks
StoneX
·
2 dagen geleden
S&P 500, Nasdaq 100 Claw Back But NVDA Cloud Looms Overhead
Profiel
Treace Medical Concepts, Inc. is a medical device company, headquartered in Ponte Vedra Beach, Florida, specializing in the design, manufacture, and marketing of foot and ankle surgical devices and biologics. Lapiplasty, Treace’s novel primary surgical product, advanced the treatment of bunions, surgically correcting the metatarsal bone, for the first time, in all three dimensions.
In March 2021, Treace announced its intent to launch an initial public offering. Trading on the Nasdaq under the ticker symbol “TMCI”, Treace opened its IPO in April 2021. Wikipedia
Over Treace Medical Concepts, Inc